Attached files
| file | filename |
|---|---|
| EX-32.2 - EX-32.2 - AGIOS PHARMACEUTICALS, INC. | agio-ex322x123120.htm |
| EX-32.1 - EX-32.1 - AGIOS PHARMACEUTICALS, INC. | agio-ex321x123120.htm |
| EX-31.2 - EX-31.2 - AGIOS PHARMACEUTICALS, INC. | agio-ex312x123120.htm |
| EX-31.1 - EX-31.1 - AGIOS PHARMACEUTICALS, INC. | agio-ex311x123120.htm |
| EX-21.1 - EX-21.1 - AGIOS PHARMACEUTICALS, INC. | agio-ex211x123120.htm |
| 10-K - 10-K - AGIOS PHARMACEUTICALS, INC. | agio-20201231.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (Nos. 333-236523, 333-229669, 333-223031, 333-216106, 333-209755, 333-201796, 333-193802, and 333-190101) and Form S-3 (No. 333-237930) of Agios Pharmaceuticals, Inc. of our report dated February 25, 2021 relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.
/s/ PricewaterhouseCoopers LLP
Boston, Massachusetts
February 25, 2021